Catechol metabolites of endogenous estrogens induce redox cycling and generate reactive oxygen species in breast epithelial cells

Carcinogenesis

Volumn 32, Issue 8, 2011, Pages 1285-1293

  Fussell, Karma C ^a   Udasin, Ronald G ^a   Smith, Peter J S ^b   Gallo, Michael A ^a   Laskin, Jeffrey D ^a  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b MARINE BIOLOGICAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYESTRADIOL; 2 HYDROXYESTRIOL; 4 HYDROXYESTRADIOL; 4 HYDROXYESTRONE; CATECHOL ESTROGEN; DIPHENYLIODONIUM SALT; HYDROGEN PEROXIDE; HYDROXYL RADICAL; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; OXIDOREDUCTASE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ADHERENT CELL; ARTICLE; BREAST EPITHELIUM; CANCER CELL CULTURE; CELL LINE MCF 10A; CELL LINE MDA MB 231; CELL LYSATE; CELL STRAIN MCF 7; CONTROLLED STUDY; HUMAN; HUMAN CELL; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL;

EID: 79961194802     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgr109     Document Type: Article

References (65)

1. Key,T. et al. (2002) Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J. Natl Cancer Inst., 94, 606-616.
2. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (Lyon France), World Health Organization, International Agency for Research on Cancer and IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (2007) Combined Estrogen-Progestogen Contraceptives and Combined Estrogen-Progestogen Menopausal Therapy. IARC Press, Lyon.
3. International Agency for Research on Cancer and World Health Organization. (1999) Hormonal Contraception and Post-menopausal Hormonal Therapy. IARC, Lyon.
4. Inoh,A. et al. (1985) Protective effects of progesterone and tamoxifen in estrogen-induced mammary carcinogenesis in ovariectomized W/Fu rats. Jpn. J. Cancer Res., 76, 699-704.
5. Noble,R.L. et al. (1975) Spontaneous and estrogen-produced tumors in Nb rats and their behavior after transplantation. Cancer Res., 35, 766-780.
6. Shull,J.D. et al. (1997) Ovary-intact, but not ovariectomized female ACI rats treated with 17beta-estradiol rapidly develop mammary carcinoma. Carcinogenesis, 18, 1595-1601.
7. Kerlan,V. et al. (1992) Nature of cytochromes P450 involved in the 2-/4-hydroxylations of estradiol in human liver microsomes. Biochem. Pharmacol., 44, 1745-1756.
8. Kato,I. et al. (1988) Factors related to late menopause and early menarche as risk factors for breast cancer. Jpn. J. Cancer Res., 79, 165-172.
9. Collaborative Group on Hormonal Factors in Breast Cancer. (1997) Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet, 350, 1047-1059.
10. Rossouw,J.E. et al. (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA, 288, 321-333.
11. Malins,D.C. et al. (2006) Oxidative changes in the DNA of stroma and epithelium from the female breast: potential implications for breast cancer. Cell Cycle, 5, 1629-1632.
12. Wang,M. et al. (1996) Lipid peroxidation-induced putative malondialdehyde-DNA adducts in human breast tissues. Cancer Epidemiol. Biomarkers Prev., 5, 705-710.
13. Embrechts,J. et al. (2003) Detection of estrogen DNA-adducts in human breast tumor tissue and healthy tissue by combined nano LC-nano ES tandem mass spectrometry. J. Am. Soc. Mass Spectrom., 14, 482-491.
14. Boyd,N.F. et al. (1991) The possible role of lipid peroxidation in breast cancer risk. Free Radic. Biol. Med., 10, 185-190.
15. Liehr,J.G. et al. (1986) Estrogen-induced endogenous DNA adduction: possible mechanism of hormonal cancer. Proc. Natl Acad. Sci. USA, 83, 5301-5305.
16. Li,K.M. et al. (2004) Metabolism and DNA binding studies of 4-hydroxyestradiol and estradiol-3,4-quinone in vitro and in female ACI rat mammary gland in vivo. Carcinogenesis, 25, 289-297.
17. Lavigne,J.A. et al. (2001) The effects of catechol-O-methyltransferase inhibition on estrogen metabolite and oxidative DNA damage levels in estradiol-treated MCF-7 cells. Cancer Res., 61, 7488-7494.
18. Cavalieri,E. et al. (2000) Estrogens as endogenous genotoxic agents-DNA adducts and mutations. J. Natl Cancer Inst. Monogr., 27, 75-93.
19. Cavalieri,E. et al. (2006) Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention. Biochim. Biophys. Acta, 1766, 63-78.
20. Bolton,J.L. et al. (1998) Role of quinoids in estrogen carcinogenesis. Chem. Res. Toxicol., 11, 1113-1127.
21. Bolton,J.L. (2002) Quinoids, quinoid radicals, and phenoxyl radicals formed from estrogens and antiestrogens. Toxicology, 177, 55-65.
22. Zhang,F. et al. (1999) The major metabolite of equilin, 4-hydroxyequilin, autoxidizes to an o-quinone which isomerizes to the potent cytotoxin 4-hydroxyequilenin-o-quinone. Chem. Res. Toxicol., 12, 204-213.
23. Spink,D.C. et al. (2001) Metabolism of equilenin in MCF-7 and MDA-MB-231 human breast cancer cells. Chem. Res. Toxicol., 14, 572-581.
24. Bolton,J.L. et al. (2008) Potential mechanisms of estrogen quinone carcinogenesis. Chem. Res. Toxicol., 21, 93-101.
25. Weisz,J. et al. (1992) Elevated 4-hydroxylation of estradiol by hamster kidney microsomes: a potential pathway of metabolic activation of estrogens. Endocrinology, 131, 655-661.
26. Liehr,J.G. et al. (1986) Cytochrome P-450-mediated redox cycling of estrogens. J. Biol. Chem., 261, 16865-16870.
27. Liehr,J.G. (2000) Role of DNA adducts in hormonal carcinogenesis. Regul. Toxicol. Pharmacol., 32, 276-282.
28. Bolton,J.L. et al. (2000) Role of quinones in toxicology. Chem. Res. Toxicol., 13, 135-160.
29. Pisha,E. et al. (2001) Evidence that a metabolite of equine estrogens, 4-hydroxyequilenin, induces cellular transformation in vitro. Chem. Res. Toxicol., 14, 82-90.
30. Roy,D. et al. (2007) Estrogen-induced generation of reactive oxygen and nitrogen species, gene damage, and estrogen-dependent cancers. J. Toxicol. Environ. Health B Crit. Rev., 10, 235-257.
31. Russo,J. et al. (2003) Estrogen and its metabolites are carcinogenic agents in human breast epithelial cells. J. Steroid Biochem. Mol. Biol., 87, 1-25.
32. Wang,Y. et al. (2008) Role of cytochrome P450 reductase in nitrofurantoininduced redox cycling and cytotoxicity. Free Radic. Biol. Med., 44, 1169-1179.
33. Wang,Y. et al. (2010) Distinct roles of cytochrome P450 reductase in mitomycin C redox cycling and cytotoxicity. Mol. Cancer Ther., 9, 1852-1863.
34. Fussell,K.C. et al. (2011) Redox cycling and increased oxygen utilization contribute to diquat-induced oxidative stress and cytotoxicity in Chinese hamster ovary cells overexpressing NADPH-cytochrome P450 reductase. Free Radic. Biol. Med., 50, 874-882.
35. Gray,J.P. et al. (2007) Paraquat increases cyanide-insensitive respiration in murine lung epithelial cells by activating an NAD(P)H:paraquat oxidoreductase: identification of the enzyme as thioredoxin reductase. J. Biol. Chem., 282, 7939-7949.
36. Mishin,V. et al. (2010) Application of the Amplex red/horseradish peroxidase assay to measure hydrogen peroxide generation by recombinant microsomal enzymes. Free. Radic. Biol. Med., 48, 1485-1491.
37. Mishin,V.M. et al. (2004) Characterization of hydroxyl radical formation by microsomal enzymes using a water-soluble trap, terephthalate. Biochem. Pharmacol., 68, 747-752.
38. Twig,G. et al. (2001) Real-time detection of reactive oxygen intermediates from single microglial cells. Biol. Bull., 201, 261-262.
39. Heart,E. et al. (2007) Rhythm of the beta-cell oscillator is not governed by a single regulator: multiple systems contribute to oscillatory behavior. Am. J. Physiol. Endocrinol. Metab., 292, E1295-E1300.
40. Henderson,B. et al. (1996) Endogenous and exogenous hormonal factors. In Harris,J.R. (ed.) Diseases of the Breast. Lippincott-Raven Publishers, Philadelphia, PA, pp. 185-200.
41. Preston-Martin,S. et al. (1990) Increased cell division as a cause of human cancer. Cancer Res., 50, 7415-7421.
42. Jensen,E.V. et al. (2003) The estrogen receptor: a model for molecular medicine. Clin. Cancer Res., 9, 1980-1989.
43. Revankar,C.M. et al. (2005) A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science, 307, 1625-1630.
44. Madak-Erdogan,Z. et al. (2008) Nuclear and extranuclear pathway inputs in the regulation of global gene expression by estrogen receptors. Mol. Endocrinol., 22, 2116-2127.
45. Kleuser,B. et al. (2008) 17-Beta-estradiol inhibits transforming growth factor-beta signaling and function in breast cancer cells via activation of extracellular signal-regulated kinase through the G protein-coupled receptor 30. Mol. Pharmacol., 74, 1533-1543.
46. Yager,J.D. et al. (2006) Estrogen carcinogenesis in breast cancer. N. Engl. J. Med., 354, 270-282.
47. Bolton,J.L. et al. (2004) Quinoids formed from estrogens and antiestrogens. Methods Enzymol., 378, 110-123.
48. Shen,L. et al. (1997) Bioreductive activation of catechol estrogenortho-quinones: aromatization of the B ring in 4-hydroxyequilenin markedly alters quinoid formation and reactivity. Carcinogenesis, 18, 1093-1101.
49. Cailleau,R. et al. (1974) Breast tumor cell lines from pleural effusions. J Natl Cancer Inst., 53, 661-674.
50. Soule,H.D. et al. (1973) A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst, 51, 1409-1416.
51. Soule,H.D. et al. (1990) Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res., 50, 6075-6086.
52. Spink,D.C. et al. (1994) The effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on estrogen metabolism in MCF-7 breast cancer cells: evidence for induction of a novel 17 beta-estradiol 4-hydroxylase. J. Steroid Biochem. Mol. Biol., 51, 251-258.
53. Lottering,M.L. et al. (1992) Effects of 17 beta-estradiol metabolites on cell cycle events in MCF-7 cells. Cancer Res., 52, 5926-5932.
54. Schutze,N. et al. (1993) Catecholestrogens are MCF-7 cell estrogen receptor agonists. J. Steroid Biochem. Mol. Biol., 46, 781-789.
55. Halliwell,B. et al. (2007) Free Radicals in Biology and Medicine. Oxford University Press, New York, NY.
56. Gage,J.C. (1968) The action of paraquat and diquat on the respiration of liver cell fractions. Biochem. J., 109, 757-761.
57. Iwahashi,H. et al. (1990) The effects of caffeic acid and its related catechols on hydroxyl radical formation by 3-hydroxyanthranilic acid, ferric chloride, and hydrogen peroxide. Arch. Biochem. Biophys., 276, 242-247.
58. Klaunig,J.E. et al. (2010) Oxidative stress and oxidative damage in carcinogenesis. Toxicol. Pathol., 38, 96-109.
59. Halliwell,B. (1999) Oxygen and nitrogen are pro-carcinogens. Damage to DNA by reactive oxygen, chlorine and nitrogen species: measurement, mechanism and the effects of nutrition. Mutat. Res., 443, 37-52.
60. Ueda,J. et al. (1998) Reactive oxygen species generated from the reaction of copper(II) complexes with biological reductants cause DNA strand scission. Arch. Biochem. Biophys., 357, 231-239.
61. Caron,P. et al. (2009) Profiling endogenous serum estrogen and estrogenglucuronides by liquid chromatography-tandem mass spectrometry. Anal. Chem., 81, 10143-10148.
62. Shimada,T. et al. (2005) Interactions of mammalian cytochrome P450, NADPH-cytochrome P450 reductase, and cytochrome b(5) enzymes. Arch. Biochem. Biophys., 435, 207-216.
63. Lu,A.Y. et al. (1969) Resolution of the cytochrome P-450-containing omega-hydroxylation system of liver microsomes into three components. J Biol. Chem., 244, 3714-3721.
64. Sarabia,S.F. et al. (1997) Mechanism of cytochrome P450-catalyzed aromatic hydroxylation of estrogens. Chem. Res. Toxicol., 10, 767-771.
65. Badawi,A.F. et al. (2001) Role of human cytochrome P450 1A1, 1A2, 1B1, and 3A4 in the 2-, 4-, and 16alpha-hydroxylation of 17beta-estradiol. Metabolism, 50, 1001-1003.